Cargando…
Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary
Autores principales: | Anderson, John, Urquhart, Scott, Spollett, Geralyn, Dandona, Paresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566923/ https://www.ncbi.nlm.nih.gov/pubmed/33132501 http://dx.doi.org/10.2337/cd20-0035 |
Ejemplares similares
-
Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (≥9%) and/or Long Duration (>8 Years): Executive Summary
por: Fonseca, Vivian A., et al.
Publicado: (2021) -
Sodium‐glucose co‐transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician
por: Dandona, Paresh, et al.
Publicado: (2017) -
Proinflammatory and Prothrombotic Effects of Hypoglycemia
por: Dandona, Paresh, et al.
Publicado: (2010) -
Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
por: Bajaj, Harpreet S, et al.
Publicado: (2023) -
Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
por: Natarajan, Sabareesh, et al.
Publicado: (2012)